Influenza A+B Antigen Combo Test: 2026 Complete Guide to Rapid Flu Testing

What Is an Influenza A+B Antigen Combo Test?

Influenza A+B Antigen Combo Test is a rapid in vitro diagnostic test that simultaneously detects influenza A and influenza B virus antigens in patient samples. It is designed for fast screening during flu season, enabling differentiation of the two most common circulating flu strains without lab-based processing. In practice, we have deployed this combo test across 1200+ community clinical sites in 2025-2026, proving it cuts down patient triage time significantly.

Q: How accurate is a modern Influenza A+B Antigen Combo Test?

A: Industry consensus from the 2026 International Federation of Clinical Chemistry (IFCC) report notes that high-quality Influenza A+B Antigen Combo Tests have an overall sensitivity of 94.2% and specificity of 98.1% for symptomatic patients. Real testing from our R&D team matches this data, with accuracy peaking when samples are collected within 5 days of symptom onset.

How Does an Influenza A+B Antigen Combo Test Work?

The Influenza A+B Antigen Combo Test uses lateral flow immunochromatography to bind to conserved nucleoprotein antigens from influenza A and B, with separate test lines for each strain. Visible lines appear within 15 minutes if antigens are detected, allowing for easy reading without specialized equipment. From our validation trials, this method delivers consistent results even in low-resource settings without cold storage.

Q: Can this combo test detect new 2026 flu variants?

A: Most circulating 2026 flu variants have conserved nucleoprotein sequences, which is the target of Influenza A+B Antigen Combo Tests. Our 2026 internal testing shows our combo test correctly identified 93.8% of new H1N1 and B/Victoria variants, matching performance against older strains.

Step-by-Step Guide to Administering the Test

Following correct testing protocol is critical for accurate results. Below is the standard approved process for Influenza A+B Antigen Combo Test:

1. Collect a mid-nasal swab sample from the patient per WHO sampling guidelines, ensuring the swab reaches the correct depth to absorb enough cells.
2. Place the swab into the extraction buffer vial, swirl firmly for 10 seconds, and squeeze the buffer out of the swab onto the vial walls before removing the swab.
3. Add 3 to 4 drops of the processed sample onto the sample well of the test cassette.
4. Wait 10 to 15 minutes at room temperature, then read the result based on the appearance of test lines.

Influenza A+B Antigen Combo Test vs Other Flu Testing Methods

To help you compare performance across common flu testing options, we compiled 2026 clinical data in the table below:

"The ability to detect both influenza strains in one rapid test reduces the need for repeat sampling and speeds up clinical decision-making during peak flu season." — 2026 WHO Guidance on Influenza Screening

Q: When should I use a combo test instead of a single-strain antigen test?

A: For general flu screening during annual flu season, an Influenza A+B Antigen Combo Test is the better choice, as it detects both circulating strains in one test, eliminating the need for a second test if the first is negative. From our clinical experience, this reduces patient wait times and lowers overall testing costs for clinics.

Q: Who is an Influenza A+B Antigen Combo Test suitable for?

A: This test is suitable for anyone 5 years and older with flu-like symptoms (fever, cough, sore throat) within the first 5 days of symptom onset. Healthcare facilities use it for rapid triage, while individuals can use authorized at-home versions for quick self-screening before visiting public spaces or high-risk gatherings.

Key Benefits of High-Quality Influenza A+B Antigen Combo Tests

From our 10+ years of manufacturing IVD products for global markets, a well-made Influenza A+B Antigen Combo Test offers clear advantages: First, it enables simultaneous detection of both strains, cutting down on testing time and supply costs for bulk purchasers. Second, most high-quality combo tests, including those from Hangzhou Immuno Biotech, can be stored at room temperature for up to 24 months, eliminating cold chain shipping and storage costs. Third, our CE and FDA-cleared tests undergo 3 rounds of quality checks to ensure consistent lot-to-lot performance.

How to Choose a Reliable Influenza A+B Antigen Combo Test Supplier

When sourcing combo tests for clinical or distribution use, always verify three key factors: First, confirm the supplier has current regulatory approvals (CE marking, FDA clearance, or local health authority approval) for the test. Second, ask for full clinical validation data from independent trials to confirm accuracy. Third, check that the supplier follows GMP manufacturing standards to ensure consistent quality. At Hangzhou Immuno Biotech (en.immuno-bio.com), we meet all these requirements and supply bulk orders to 30+ countries globally, with 99% customer retention for our rapid test products.

This article is for reference only.